Evidence map›Paper›PMID 35155283›Full record

ReviewFrontiers in cellular and infection microbiology2022

Crosstalk Between the Gut Microbiota and Epithelial Cells Under Physiological and Infectious Conditions.

An Zhou, Yi Yuan, Min Yang, Yujiao Huang, Xin Li, Shengpeng Li, Shiming Yang, Bo Tang

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in cellular and infection microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. The Effects of FeedingMicroorganisms · 2025
    Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

An ZhouDepartment of Gastroenterology, Xinqiao Hospital, Third Military Medical University, Chongqing, China.
Yi YuanInstitution of Basic Medicine, Third Military Medical University, Chongqing, China.
Min YangDepartment of Gastroenterology, Xinqiao Hospital, Third Military Medical University, Chongqing, China.
Yujiao HuangThe First Clinical College, ChongQing Medical University, Chongqing, China.
Xin LiDepartment of Gastroenterology, Xinqiao Hospital, Third Military Medical University, Chongqing, China.
Shengpeng LiDepartment of Gastroenterology, Xinqiao Hospital, Third Military Medical University, Chongqing, China.
Shiming YangDepartment of Gastroenterology, Xinqiao Hospital, Third Military Medical University, Chongqing, China.
Bo TangDepartment of Gastroenterology, Xinqiao Hospital, Third Military Medical University, Chongqing, China.
Army Medical University · CNXinqiao Hospital · CNChongqing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The gastrointestinal tract (GIT) is considered the largest immunological organ, with a diverse gut microbiota, that contributes to combatting pathogens and maintaining human health. Under physiological conditions, the crosstalk between gut microbiota and intestinal epithelial cells (IECs) plays a crucial role in GIT homeostasis. Gut microbiota and derived metabolites can compromise gut barrier integrity by activating some signaling pathways in IECs. Conversely, IECs can separate the gut microbiota from the host immune cells to avoid an excessive immune response and regulate the composition of the gut microbiota by providing an alternative energy source and releasing some molecules, such as hormones and mucus. Infections by various pathogens, such as bacteria, viruses, and parasites, can disturb the diversity of the gut microbiota and influence the structure and metabolism of IECs. However, the interaction between gut microbiota and IECs during infection is still not clear. In this review, we will focus on the existing evidence to elucidate the crosstalk between gut microbiota and IECs during infection and discuss some potential therapeutic methods, including probiotics, fecal microbiota transplantation (FMT), and dietary fiber. Understanding the role of crosstalk during infection may help us to establish novel strategies for prevention and treatment in patients with infectious diseases, such as

Indexed as

Clostridioides difficileCOVID-19Gastrointestinal MicrobiomeEpithelial CellsFecal Microbiota TransplantationHumansIntestinal MucosaSARS-CoV-2COVID-19epithelial cellsgut microbiotainfectionprobiotics

Identifiers

PMID35155283
PMCPMC8829037
OpenAlexW4210686869

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.